BMY - Bristol-Myers Squibb Co
301
$59.37
-$0.34 (-0.569%)
At market close
$59.19
-$0.18 (-0.306%)
After Hours 3/18/26, 10:59 PM
Score3.86/5
Price Targets
These are one year price targets for: 2027-02-21
High:
$78.75
32.6%
Avg:
$62.03
4.5%
Low:
$33.43
-43.7%
% change is relative to the current stock price ($59.37).
Most Recent Recommendations
3.53
Good
17%
Strong Buy (6)
25%
Buy (9)
53%
Hold (19)
6%
Sell (2)
0%
Strong Sell (0)
Revenue Estimate
- Past Revenue
- Avg
- High
- Low
EPS Estimate
- Past EPS
- Avg
- High
- Low
Revenue Estimate as % change
YoY is the % change of each analyst estimate, relative to the prior year
| 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | |
|---|---|---|---|---|---|---|---|---|
| Low | -2.96% | -5.54% | -12.6% | -10.9% | -4.33% | -3.32% | -5.90% | -6.76% |
| Avg | -1.84% | -2.12% | -11.9% | -8.46% | -2.95% | 1.12% | 1.62% | -0.92% |
| High | -1.40% | -0.47% | -10.0% | -0.02% | -6.19% | 2.40% | 9.09% | -0.90% |
EPS Estimate as % change
YoY is the % change of each analyst estimate, relative to the prior year
| 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | |
|---|---|---|---|---|---|---|---|---|
| Low | 4.85% | -10.4% | -19.9% | -20.0% | -7.49% | 32.1% | -8.96% | -3.37% |
| Avg | 4.47% | -2.33% | -12.2% | -8.06% | -0.36% | 5.36% | -0.12% | 3.90% |
| High | 4.09% | 7.86% | -10.9% | -5.73% | 8.68% | 6.55% | -4.50% | -3.77% |
Recommendation Trends
- Strong Sells
- Sells
- Holds
- Buys
- Strong Buys
Latest Analyst Ratings
Institution | Action | Grade | Old Grade | Date |
|---|---|---|---|---|
| HSBC | Maintain | Hold | Hold | 2026-03-17 |
| RBC Capital | Init | Sector Perform | -- | 2026-02-25 |
| Piper Sandler | Maintain | Overweight | Overweight | 2026-02-23 |
| Barclays | Init | Overweight | -- | 2026-02-20 |
| Wells Fargo | Maintain | Equal-Weight | Equal-Weight | 2026-02-06 |
| Citigroup | Maintain | Neutral | Neutral | 2026-02-06 |
| Guggenheim | Maintain | Buy | Buy | 2026-02-06 |
| Piper Sandler | Maintain | Overweight | Overweight | 2026-01-28 |
| Citigroup | Maintain | Neutral | Neutral | 2026-01-27 |
| Leerink Partners | Maintain | Outperform | Outperform | 2026-01-13 |